ADVERTISEMENT

Mold-Tek Packaging Q1 Review — Pharma, Paints To Drive FY26 Growth, Says PL Capital Maintaining 'Add'

Mold-Tek Packaging's outlook seems positive given rising business from leading paint and FMCG companies and scale up in pharma business.

<div class="paragraphs"><p>Mold-Tek Packaging guided for 18-20% sales growth for FY26 led by food and fmcg. (photo: company website)</p></div>
Mold-Tek Packaging guided for 18-20% sales growth for FY26 led by food and fmcg. (photo: company website)

Mold-Tek Packaging reported a 15% year-on-year volume growth, driven by strong performance in the paints, foods, and FMCG segments. Despite a shorter summer, F&F segment recorded robust volume growth of 13.57%. The Panipat plant is scheduled to begin production for the F&F segment from August onwards.

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

PL Capital Report

We increase Mold-Tek Packaging Ltd.'s FY26/FY27 estimate by 6.1%/7.1% led by positive outlook in the near term with-

  1. Growing traction in pharma business with superior Ebitda/kg of ~Rs 100,

  2. Double digit volume growth guidance for paints led by enhanced capacity for Aditya Birla group,

  3. Asian paint moving towards In mould labeling with all four plant IML ready by Mold-Tek Packaging and

  4. Healthy margin outlook for ( Rs 41- 42 Ebitda/Kg) FY26/27 led by growing traction in food, paints and pharma. Mold-Tek Packaging has shown strong rebound in Ebitda/kg to Rs 41 in Q1 FY26 given superior mix and volume growth.

The outlook seems positive given rising business from leading paint and FMCG companies and scale up in pharma business.

We estimate Ebitda/kg to increase to Rs 41.2/43.8 over FY26 and FY27. We estimate a 17.2% Sales CAGR and 30.3% EPS CAGR over FY25-27 post 25% EPS decline in previous three years.

We assign a PE of 26x on Mar27 valuing the company at Rs 805 (Rs 723 earlier). Retain ‘Accumulate’.

Click on the attachment to read the full report:

PL Capital Mold-Tek Packaging Q1Fy26 Results Review.pdf
Opinion
IndusInd Bank Q1 Results Review: Motilal Oswal Maintains 'Neutral' Stance, Revises Target Price — Here's Why

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit